Investigating Neuropharmacological Features of the Cortical Activity of Cannabidiol GWP42003 P—A Phase 1 Clinical Trial
Highlights What are the main findings? A dose of purified cannabidiol did not significantly alter cortical excitability or established GABAergic biomarkers. The drug exhibited a trend toward increased alpha and decreased delta neural synchronization compared to placebo. What are the implications of the main findings? T...